RxDoctor Payments Data

Richard Whitlock, MD

Family Medicine · Moss Point, MSNPI 1598797870

Payments from drug & device makers

$2,443in general payments, 2019–2025

Across 148 payments — averaging $16.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$349
  • Novo Nordisk$330
  • AbbVie$302
  • Lilly USA, LLC$247
  • AstraZeneca$204
  • Pfizer$168
  • plus $845 from 19 others

What the payments were for

  • Food & beverage$2,435100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,443 in reported general payments places this provider in the 70th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$186,298
Medicare patients
610
Services billed
2,729

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide126$182,784
EliquisApixaban87$105,782
JardianceEmpagliflozin58$75,138
MounjaroTirzepatide42$52,036
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$49,626
TrulicityDulaglutide37$45,468
FarxigaDapagliflozin Propanediol42$36,506
Tresiba Flextouch U-100Insulin Degludec62$36,180
Xigduo XrDapaglifloz Propaned/Metformin37$33,736
LinzessLinaclotide30$32,868
Breztri AerosphereBudesonide/Glycopyr/Formoterol26$26,860
XareltoRivaroxaban27$24,742
JanuviaSitagliptin Phosphate15$19,009
MyrbetriqMirabegron29$17,428
SymbicortBudesonide/Formoterol Fumarate31$12,882

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$330$182,784126 claims
PfizerEliquis$168$105,78287 claims
Lilly USA, LLCMounjaro, Trulicity$247$97,50479 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$204$76,24899 claims
GSKTrelegy Ellipta, Breo Ellipta$129$57,55649 claims
AbbVieLinzess, Synthroid$302$37,192127 claims
MerckJanuvia, Janumet$28$31,33027 claims
Johnson & JohnsonXarelto$15$24,74227 claims
Astellas Pharma US IncMyrbetriq$97$17,42829 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Moss Point

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →